Decrease in cell adhesion molecules by treatment with anti-tumor necrosis factor alpha monoclonal antibody.
Smith
M D
MD
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000378:metabolism / Q000628:therapy*; D017252:CD3 Complex / Q000276:immunology; D019040:E-Selectin / Q000378:metabolism*; D006801:Humans; D013583:Synovial Membrane / Q000378:metabolism*; D013601:T-Lymphocytes / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D017252:CD3 Complex; D019040:E-Selectin; D014409:Tumor Necrosis Factor-alpha; D019010:Vascular Cell Adhesion Molecule-1